lansoprazole has been researched along with Esophageal Stricture in 6 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy of lansoprazole 30 mg given in the morning compared with high-dose ranitidine 300 mg twice daily in the treatment of patients with oesophageal strictures." | 9.08 | Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine. ( Christian, J; Foster, CS; Garrett, AD; Gough, AL; Langworthy, CH; Swarbrick, ET, 1996) |
| "To determine the efficacy of lansoprazole 30 mg given in the morning compared with high-dose ranitidine 300 mg twice daily in the treatment of patients with oesophageal strictures." | 5.08 | Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine. ( Christian, J; Foster, CS; Garrett, AD; Gough, AL; Langworthy, CH; Swarbrick, ET, 1996) |
| "In our study omeprazole was superior to either lansoprazole or pantoprazole in the maintenance treatment of complicated gastro-oesophageal reflux disease." | 5.08 | A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis. ( Diehl, KL; Geyer, P; Jaspersen, D; Martens, E; Schoeppner, H, 1998) |
| "To review the literature on the treatment of gastroesophageal reflux disease (GERD) with emphasis on pharmacological aspects." | 2.43 | Treatment of gastroesophageal reflux disease. ( Camargos, PA; Guimarães, EV; Marguet, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uygun, I | 1 |
| Arslan, MS | 1 |
| Aydogdu, B | 1 |
| Okur, MH | 1 |
| Otcu, S | 1 |
| Ibrahim, A | 1 |
| Cole, RA | 1 |
| Qureshi, WA | 1 |
| Helaly, AZ | 1 |
| Jamecci, A | 1 |
| Graham, DY | 1 |
| Ayub, K | 1 |
| Guimarães, EV | 1 |
| Marguet, C | 1 |
| Camargos, PA | 1 |
| Swarbrick, ET | 1 |
| Gough, AL | 1 |
| Foster, CS | 1 |
| Christian, J | 1 |
| Garrett, AD | 1 |
| Langworthy, CH | 1 |
| Jaspersen, D | 1 |
| Diehl, KL | 1 |
| Schoeppner, H | 1 |
| Geyer, P | 1 |
| Martens, E | 1 |
| Yokohama, S | 1 |
| Ishizeki, K | 1 |
| Tamori, K | 1 |
| Inaba, M | 1 |
| Tani, M | 1 |
| Makino, I | 1 |
1 review available for lansoprazole and Esophageal Stricture
| Article | Year |
|---|---|
Treatment of gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Anti-Ulcer Agents; Barre | 2006 |
3 trials available for lansoprazole and Esophageal Stricture
| Article | Year |
|---|---|
Schatzki's ring: to cut or break an unresolved problem.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Dilatation; Electrosurgery; En | 2004 |
Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dilatation; Double-Blind Method; Drug Ad | 1996 |
A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Deglutition | 1998 |
2 other studies available for lansoprazole and Esophageal Stricture
| Article | Year |
|---|---|
Fluoroscopic balloon dilatation for caustic esophageal stricture in children: an 8-year experience.
Topics: Adolescent; Anesthesia, General; Anti-Ulcer Agents; Antibiotic Prophylaxis; Burns, Chemical; Caustic | 2013 |
[Administration of proton pump inhibitor caused esophageal stenosis in two patients with severe reflux esophagitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Drug Administration Schedule; Esophageal Stenosis; Es | 2001 |